Vanguard Portfolio Management
APLS

Vanguard Portfolio Management’s Apellis Pharmaceuticals APLS Stock Holding History

Vanguard Portfolio Management’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,404,559
Closed -$217M – 3149
2026
Q1 		$217M Buy
+5,404,559
New +$116M 0.01% 1092

Other funds holding APLS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Vanguard Portfolio Management's APLS Position: Q2 2026 in Review

Vanguard Portfolio Management sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 5,404,559 shares — an estimated $217M sold.

Vanguard Portfolio Management first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $217M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

  • Vanguard Portfolio Management reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Vanguard Portfolio Management sold 5,404,559 Apellis Pharmaceuticals shares in Q2 2026, an estimated $217M.
  • Vanguard Portfolio Management first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Vanguard Portfolio Management's Apellis Pharmaceuticals position peaked at $217M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.